Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.86−0.05 (-4.98%)
Close on Nov 16, 2026Market cap $44.69MP/E –Yield –
Talphera price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Talphera's price to sales ratio was 411.2× on Aug 29, 2025, against 26.9× a year earlier. Over the last 5 years it ranged from 8.4× to 411.2×, with a median of 34.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Aug 29, 2025 | 411.2× | +379.5 |
| 2024 | Dec 31, 2024 | 31.8× | −1.6 |
| 2023 | Jan 31, 2023 | 33.4× | −4.3 |
| 2022 | Dec 30, 2022 | 37.7× | +18.9 |
| 2021 | Dec 31, 2021 | 18.8× | −3.0 |
| 2020 | Dec 31, 2020 | 21.8× | −47.4 |
| 2019 | Dec 31, 2019 | 69.2× | +6.5 |
| 2018 | Dec 31, 2018 | 62.7× | +55.3 |
| 2017 | Dec 29, 2017 | 7.3× | −2.0 |
| 2016 | Dec 30, 2016 | 9.3× | −0.3 |
| 2015 | Dec 31, 2015 | 9.6× | +0.6 |
| 2014 | Dec 31, 2014 | 9.0× | −127.3 |
| 2013 | Dec 31, 2013 | 136.3× | +64.5 |
| 2012 | Dec 31, 2012 | 71.8× | – |
See a number that looks wrong?